Starpharma Holdings Limited
OTC: SPHRF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Cheryl Maley
- Employees
- 40
- Headquarters
- Abbotsford, Australia
- IPO year
- 2007
- Market cap
- $218.9M
- Website
- https://starpharma.com
Loading SPHRF…
Loading profile data…Frequently asked questions about SPHRF
What does Starpharma Holdings Limited (SPHRF) do?
Starpharma Holdings Limited is a global biopharmaceutical firm dedicated to the investigation, advancement, and marketing of its proprietary dendrimer-based products for pharmaceutical, life science, and other diverse applications. Among its commercialized offerings is VivaGel, an antibiotic-free therapy designed for both preventing and managing...
Where does SPHRF trade?
Starpharma Holdings Limited (SPHRF) trades on the Other OTC.
What sector is SPHRF in?
Starpharma Holdings Limited (SPHRF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Starpharma Holdings Limited?
Cheryl Maley is the chief executive officer of Starpharma Holdings Limited (SPHRF).
Where is Starpharma Holdings Limited headquartered?
Starpharma Holdings Limited is headquartered in Australia.
Does SPHRF pay a dividend?
Starpharma Holdings Limited (SPHRF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SPHRF go public?
Starpharma Holdings Limited (SPHRF) completed its initial public offering in 2007.